If approved, mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across the globe.
WHO recommends strains 2026 for Northern Hemisphere flu vaccines, updating all three viral strains to improve protection against emerging variants.
It’s unsurprising, but disappointing nonetheless: The president’s pick for surgeon general is a vaccine skeptic.
The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...
The Alabama Department of Public Health says the flu can circulate year-round.
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.
The company’s mRNA flu shot, if approved, could be available for the 2026-27 flu season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results